Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSC Transplantation vs Classical Therapy in Liver Cirrhosis
NCT01718587Phase 2Unknown
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Nov 2012
- Primary completion
- May 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human umbilical cord mesenchymal stem cells in Liver cirrhosis (LC) (2 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: Liver volume calculated by MRI at 12 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01718587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718587.